In the Asian population, epidermal growth factor receptor (EGFR) mutation is the most common genetic alteration, found in approximately 40%–50% of all NSCLC patients, and as high as 75%–80% among never‐smoking Asians.3, 4. This evidence concerns the gene EGFR and non-small cell lung carcinoma.